89 related articles for article (PubMed ID: 1728414)
1. Detection of nuclear matrix proteins in serum from cancer patients.
Miller TE; Beausang LA; Winchell LF; Lidgard GP
Cancer Res; 1992 Jan; 52(2):422-7. PubMed ID: 1728414
[TBL] [Abstract][Full Text] [Related]
2. Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins.
Partin AW; Briggman JV; Subong EN; Szaro R; Oreper A; Wiesbrock S; Meyer J; Coffey DS; Epstein JI
Urology; 1997 Nov; 50(5):800-8. PubMed ID: 9372899
[TBL] [Abstract][Full Text] [Related]
3. Identification of nuclear matrix protein alterations associated with human colon cancer.
Brünagel G; Vietmeier BN; Bauer AJ; Schoen RE; Getzenberg RH
Cancer Res; 2002 Apr; 62(8):2437-42. PubMed ID: 11956108
[TBL] [Abstract][Full Text] [Related]
4. Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A
Anticancer Res; 1999; 19(4A):2415-20. PubMed ID: 10470168
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer-associated nuclear matrix proteins.
Getzenberg RH; Konety BR; Oeler TA; Quigley MM; Hakam A; Becich MJ; Bahnson RR
Cancer Res; 1996 Apr; 56(7):1690-4. PubMed ID: 8603421
[TBL] [Abstract][Full Text] [Related]
6. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
[TBL] [Abstract][Full Text] [Related]
7. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
[TBL] [Abstract][Full Text] [Related]
8. Electrophoretic analysis of nuclear matrix proteins in human hepatocellular carcinoma.
Chew EC; Liew CT; Wu S; Yang L; Yam HF; Wang SW; Lee SM; Wang ZH; Chew-Cheng SB
Anticancer Res; 1997; 17(5A):3581-5. PubMed ID: 9413206
[TBL] [Abstract][Full Text] [Related]
9. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
[TBL] [Abstract][Full Text] [Related]
10. Identification of nuclear matrix proteins in the cancer and normal rat prostate.
Getzenberg RH; Pienta KJ; Huang EY; Coffey DS
Cancer Res; 1991 Dec; 51(24):6514-20. PubMed ID: 1742724
[TBL] [Abstract][Full Text] [Related]
11. Nuclear matrix proteins as cancer markers.
Davido T; Getzenberg RH
J Cell Biochem Suppl; 2000; Suppl 35():136-41. PubMed ID: 11389543
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric analysis of nuclear matrix proteins: method and potential applications.
Dynlacht JR; Henthorn J; O'Nan C; Dunn ST; Story MD
Cytometry; 1996 Aug; 24(4):348-59. PubMed ID: 8866219
[TBL] [Abstract][Full Text] [Related]
13. Identification of proteins immunologically related to vertebrate lamins in the nuclear matrix of the myxomycete Physarum polycephalum.
Lang S; Loidl P
Eur J Cell Biol; 1993 Jun; 61(1):177-83. PubMed ID: 8223702
[TBL] [Abstract][Full Text] [Related]
14. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Konety BR; Nguyen TS; Dhir R; Day RS; Becich MJ; Stadler WM; Getzenberg RH
Clin Cancer Res; 2000 Jul; 6(7):2618-25. PubMed ID: 10914702
[TBL] [Abstract][Full Text] [Related]
15. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
[TBL] [Abstract][Full Text] [Related]
16. NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer.
Briggman J; Genduso R; Camara C; Healy B; Shapiro K; Roos R; Merrifield S; Lifter J; Wu YJ; Elder E; Talamonti M
Anticancer Res; 1999; 19(4A):2411-4. PubMed ID: 10470167
[TBL] [Abstract][Full Text] [Related]
17. Critical increment of Lewis blood group antigen in serum by cancer found by photothermal immunoassay.
Kimura H; Kitamori T; Sawada T
Anal Biochem; 1999 Oct; 274(1):98-103. PubMed ID: 10527501
[TBL] [Abstract][Full Text] [Related]
18. Death-induced changes to the nuclear matrix: the use of anti-nuclear matrix antibodies to study agents of apoptosis.
Miller T; Beausang LA; Meneghini M; Lidgard G
Biotechniques; 1993 Dec; 15(6):1042-7. PubMed ID: 8292336
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
20. Nuclear matrix proteins in normal and breast cancer cells.
Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
